Cannabis and Cannabinoids in Multiple Sclerosis: From Experimental Models to Clinical Practice—A Review
Sign Up to like & getrecommendations! Published in 2022 at "American Journal of Therapeutics"
DOI: 10.1097/mjt.0000000000001568
Abstract: Background: As far as 80% of people diagnosed with multiple sclerosis (MS) experience disabling symptoms in the course of the disease, such as spasticity and neuropathic pain. As first-line symptomatic therapy is associated with important… read more here.
Keywords: cannabinoids multiple; experimental models; cannabis cannabinoids; multiple sclerosis ... See more keywords
Therapeutic cannabinoids in multiple sclerosis: immunomodulation revisited
Sign Up to like & getrecommendations! Published in 2018 at "European Journal of Neurology"
DOI: 10.1111/ene.13658
Abstract: Cannabinoids are compounds with pleiotropic properties that act on the cannabinoid receptors, CB1 and CB2, and are divided into endocannabinoids, the endogenous ligands of these receptors, synthetic cannabinoids and phytocannabinoids. The latter are derived from… read more here.
Keywords: neurology; immunomodulation revisited; multiple sclerosis; therapeutic cannabinoids ... See more keywords